August 18, 2017
A New York federal judge on Friday signed off on $44.6 million in fees for attorneys who secured a $210 million settlement to end a proposed class action by Salix Pharmaceuticals Ltd. shareholders claiming the company misrepresented inventory levels to falsely inflate its stock price.
June 20, 2017
Attorneys who secured a tentative $210 million settlement to end a proposed class action by Salix Pharmaceuticals Ltd. shareholders claiming the company misrepresented inventory levels to falsely inflate its stock price asked a New York federal judge Monday for $44.6 million in fees.
March 27, 2017
Shareholders in a proposed class action asked a New York federal court on Friday for preliminary approval of a $210 million settlement to end a lawsuit accusing Salix Pharmaceuticals Ltd. of inflating stock prices by knowingly misrepresenting the company's wholesale inventory levels.